{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:09:06Z","timestamp":1787317746340,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T00:00:00Z","timestamp":1515110400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.ebiom.2018.01.007","type":"journal-article","created":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T22:05:21Z","timestamp":1515535521000},"page":"143-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Acetylcholine Receptor Antibody Titers and Clinical Course after Influenza Vaccination in Patients with Myasthenia Gravis: A Double-Blind Randomized Controlled Trial (ProPATIent-Trial)"],"prefix":"10.1016","volume":"28","author":[{"given":"Bj\u00f6rn","family":"Tackenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"Blaes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Eienbr\u00f6ker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Schade-Brittinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Wellek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Deschauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Eickmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Dieter","family":"Klenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Helge","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2018.01.007_bb0005","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/mus.22077","article-title":"Safety of influenza and H1N1 vaccinations in patients with myasthenia gravis, and patient compliance","volume":"43","author":"Auriel","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ebiom.2018.01.007_bb0010","doi-asserted-by":"crossref","first-page":"e29249","DOI":"10.1371\/journal.pone.0029249","article-title":"Influenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspective","volume":"6","author":"Beck","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2018.01.007_bb0015","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1212\/WNL.33.10.1316","article-title":"Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity","volume":"33","author":"Besinger","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.ebiom.2018.01.007_bb0020","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1007\/s00415-015-7963-5","article-title":"Myasthenia gravis: a clinical-immunological update","volume":"263","author":"Binks","year":"2016","journal-title":"J. Neurol."},{"key":"10.1016\/j.ebiom.2018.01.007_bb0025","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2165\/00003495-200060010-00004","article-title":"Humoral immune response to influenza vaccination in patients from high risk groups","volume":"60","author":"Brydak","year":"2000","journal-title":"Drugs"},{"issue":"46","key":"10.1016\/j.ebiom.2018.01.007_bb0030","article-title":"A systematic review of population based epidemiological studies in Myasthenia gravis","volume":"10","author":"Carr","year":"2010","journal-title":"BMC Neurol."},{"key":"10.1016\/j.ebiom.2018.01.007_bb0035","first-page":"1203","article-title":"Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity","volume":"21","author":"Chalmers","year":"1994","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.ebiom.2018.01.007_bb0040","series-title":"Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie","author":"Deutsche Gesellschaft f\u00fcr Neurologie","year":"2012"},{"key":"10.1016\/j.ebiom.2018.01.007_bb0045","doi-asserted-by":"crossref","first-page":"6358","DOI":"10.1016\/j.vaccine.2009.06.090","article-title":"Antibody quantity versus quality after influenza vaccination","volume":"27","author":"Feng","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.ebiom.2018.01.007_bb0050","first-page":"1","article-title":"Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010","volume":"59","author":"Fiore","year":"2010","journal-title":"MMWR Recomm. Rep."},{"key":"10.1016\/j.ebiom.2018.01.007_bb0055","series-title":"Influenza: Pr\u00e4vention, Diagnostik, Therapie und \u00f6ffentliche Gesundheit","author":"Haas","year":"2009"},{"key":"10.1016\/j.ebiom.2018.01.007_bb0060","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/jnnp.2008.144980","article-title":"Immunosuppressant drugs for myasthenia gravis","volume":"80","author":"Hart","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ebiom.2018.01.007_bb0065","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/ana.410170304","article-title":"Myasthenia gravis: reactivation of clinical disease and of autoimmune factors after discontinuation of long-term azathioprine","volume":"17","author":"Hohlfeld","year":"1985","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.ebiom.2018.01.007_bb0070","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.autrev.2006.09.012","article-title":"Influenza vaccination in systemic lupus erythematosus: safe and protective?","volume":"6","author":"Holvast","year":"2007","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.ebiom.2018.01.007_bb0075","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1136\/ard.2008.092924","article-title":"Wegener's granulomatosis patients show an adequate antibody response to influenza vaccination","volume":"68","author":"Holvast","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ebiom.2018.01.007_bb0080","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/rheumatology\/kep200","article-title":"Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study","volume":"48","author":"Holvast","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ebiom.2018.01.007_bb0085","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/nep.12416","article-title":"Randomized trial investigating the safety and efficacy of influenza vaccination in patients with antineutrophil cytoplasmic antibody-associated vasculitis","volume":"20","author":"Jeffs","year":"2015","journal-title":"Nephrology (Carlton)"},{"issue":"5","key":"10.1016\/j.ebiom.2018.01.007_bb0090","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000065639","article-title":"Epidemiology of myasthenia gravis: a population-based study in Stockholm, Sweden","volume":"21","author":"Kalb","year":"2002","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.ebiom.2018.01.007_bb0095","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s10072-014-1659-y","article-title":"Predictors of outcome of myasthenic crisis","volume":"35","author":"Kalita","year":"2014","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.ebiom.2018.01.007_bb0100","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1212\/WNL.0000000000001302","article-title":"Randomized trial of vaccination in fingolimod-treated patients with multiple sclerosis","volume":"84","author":"Kappos","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.ebiom.2018.01.007_bb0105","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00002030-199404000-00008","article-title":"Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes","volume":"8","author":"Kroon","year":"1994","journal-title":"AIDS"},{"key":"10.1016\/j.ebiom.2018.01.007_bb0110","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1212\/WNL.48.2.312","article-title":"A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis","volume":"48","author":"Miller","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.ebiom.2018.01.007_bb0115","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1055\/s-2007-992151","article-title":"Epidemiological research","volume":"83","author":"Okasha","year":"2007","journal-title":"Allg. Med."},{"key":"10.1016\/j.ebiom.2018.01.007_bb0120","first-page":"283","article-title":"Impfempfehlungen der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch-Institut\/Stand: Juli 2012","volume":"30","author":"RKI, Robert-Koch-Institut","year":"2012","journal-title":"Epidemiol. Bull."},{"key":"10.1016\/j.ebiom.2018.01.007_bb0125","first-page":"568074","article-title":"The long-term effects of a kampo medicine, juzentaihoto, on maintenance of antibody titer in elderly people after influenza vaccination","author":"Saiki","year":"2013","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.ebiom.2018.01.007_bb0130","first-page":"224","article-title":"Correlation between serum anti-acetylcholine-receptor antibody-levels and clinical state under immunosuppressive therapy in Myasthenia-gravis","volume":"234","author":"Schumm","year":"1984","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.ebiom.2018.01.007_bb0135","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1750-2659.2011.00268.x","article-title":"Quantitative review of antibody response to inactivated seasonal influenza vaccines","volume":"6","author":"Seidman","year":"2012","journal-title":"Influenza Other Respir. Viruses"},{"key":"10.1016\/j.ebiom.2018.01.007_bb0140","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3988\/jcn.2017.13.4.325","article-title":"The impacts of influenza infection and vaccination on exacerbation of myasthenia gravis","volume":"13","author":"Seok","year":"2017","journal-title":"J. Clin. Neurol."},{"key":"10.1016\/j.ebiom.2018.01.007_bb0145","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1749-6632.1981.tb33739.x","article-title":"Patterns of acetylcholine receptor antibody fluctuation in myasthenia gravis","volume":"377","author":"Seybold","year":"1981","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ebiom.2018.01.007_bb0150","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/(SICI)1096-9071(200005)61:1<85::AID-JMV14>3.0.CO;2-H","article-title":"Efficacy of influenza vaccination in adult liver transplant recipients","volume":"61","author":"Soesman","year":"2000","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.ebiom.2018.01.007_bb0155","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0072-9752(07)01505-9","article-title":"The immunopathogenesis of myasthenia gravis","volume":"91","author":"Sommer","year":"2008","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.ebiom.2018.01.007_bb0160","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1002\/jmv.20936","article-title":"Lack of effect of a booster dose of influenza vaccine in hemodialysis patients","volume":"79","author":"Tanzi","year":"2007","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.ebiom.2018.01.007_bb0165","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1212\/WNL.48.5.1253","article-title":"Myasthenic crisis: clinical features, mortality, complications, and risk factors for prolonged intubation","volume":"48","author":"Thomas","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.ebiom.2018.01.007_bb0170","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/ana.410100506","article-title":"Humoral immunity in myasthenia gravis: biochemical characterization of acquired antireceptor antibodies and clinical correlations","volume":"10","author":"Tindall","year":"1981","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ebiom.2018.01.007_bb0175","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.autrev.2008.07.008","article-title":"Autoimmune response following annual influenza vaccination in 92 apparently healthy adults","volume":"8","author":"Toplak","year":"2008","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.ebiom.2018.01.007_bb0180","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1248\/yakushi.131.1733","article-title":"MF59 adjuvanted seasonal and pandemic influenza vaccines","volume":"131","author":"Tsai TF","year":"2011","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.ebiom.2018.01.007_bb0185","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1073\/pnas.79.1.188","article-title":"Specificities of antibodies to acetylcholine receptors in sera from myasthenia gravis patients measured by monoclonal antibodies","volume":"79","author":"Tzartos","year":"1982","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ebiom.2018.01.007_bb0190","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1177\/0961203311429554","article-title":"Influenza vaccination can induce new-onset anticardiolipins but not \u03b22-glycoprotein-I antibodies among patients with systemic lupus erythematosus","volume":"21","author":"Vista","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.ebiom.2018.01.007_bb0195","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1177\/1941875210382918","article-title":"Myasthenic crisis","volume":"1","author":"Wendell","year":"2011","journal-title":"Neurohospitalist"},{"key":"10.1016\/j.ebiom.2018.01.007_bb0200","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1602489","article-title":"Randomized trial of thymectomy in Myasthenia gravis","volume":"375","author":"Wolfe","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ebiom.2018.01.007_bb0205","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/mus.21440","article-title":"Safety of influenza vaccination in patients with myasthenia gravis: a population-based study","volume":"40","author":"Zinman","year":"2009","journal-title":"Muscle Nerve"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396418300070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396418300070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:49:45Z","timestamp":1762454985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396418300070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":41,"alternative-id":["S2352396418300070"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2018.01.007","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acetylcholine Receptor Antibody Titers and Clinical Course after Influenza Vaccination in Patients with Myasthenia Gravis: A Double-Blind Randomized Controlled Trial (ProPATIent-Trial)","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2018.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}